Improved Anticoagulation Guideline Adherence and Clinical Outcome Through Hospital-Wide Atrial Fibrillation Alarming

Tzu-Wei Liao1, Wei-Ta Chen2,3

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University.

Insights

A hospital-wide atrial fibrillation (AF) screening system significantly improved direct oral anticoagulant (DOAC) adherence in AF patients. This intervention reduced stroke rates while increasing minor bleeding events.

Area of Science:

  • Cardiology
  • Clinical Pharmacy
  • Public Health

Background:

  • Direct oral anticoagulants (DOACs) are indicated for stroke prevention in atrial fibrillation (AF).
  • A significant proportion of AF patients remain untreated or undertreated with oral anticoagulants (OACs).
  • Off-label DOAC dosing is common, impacting therapeutic efficacy and safety.

Purpose of the Study:

  • To evaluate the impact of a hospital-wide AF screening system on OAC guideline adherence.
  • To assess the effect of improved adherence on clinical outcomes, including stroke and bleeding rates.

Main Methods:

  • Implementation of a systematic AF screening protocol utilizing electrocardiograms (ECGs) for all hospitalized patients.
  • Calculation of CHA2DS2-VAS scores and recommendation of appropriate DOACs to primary care teams.
  • Prospective monitoring of DOAC guideline adherence, annual stroke rates, and bleeding events.

Main Results:

  • DOAC guideline adherence increased from 40.6% at baseline to 82.5% post-intervention, with sustained adherence after discharge.
  • Annual stroke rates decreased for patients on guideline-recommended DOACs.
  • Patients adhering to DOAC guidelines experienced a significantly higher rate of minor bleeding but no significant difference in major bleeding.

Conclusions:

  • A hospital-wide AF screening system effectively enhances DOAC guideline adherence in AF patients.
  • Improved adherence is associated with a reduction in annual stroke rates.
  • Increased minor bleeding is a potential consequence of guideline-adherent DOAC therapy.
Abstract